Cross-species representation learning aligns mouse and human neural dynamics and tracks clinical drug efficacy
Preclinical models poorly predict human drug efficacy, particularly in neurological disorders.
Key points
- We develop a dual-rule contrastive learning framework that aligns corresponding mouse and human states while preserving separation between distinct phenotypes.
- This framework recovered conserved sensory-response structure across species and, in epilepsy, resolved distinct relationships between three mouse models and heterogeneous human patient populations.
- The framework also identified shared disease-associated neural dynamics between Fmr1-knockout mice and human 16p11.2 copy-number variant carriers despite differences in genetic aetiology and recording modality.
- Together, these findings show the potential of cross-species neural representation learning to map heterogeneous human disease onto experimentally tractable preclinical states and assess whether interventions restore human-relevant circuit function.
Sources (1)
- [1]Cross-species representation learning aligns mouse and human neural dynamics and tracks clinical drug efficacyarXiv (AI, ML, NLP, CV, robotics, multi-agent) · Oct 8, 04:19 AM
Preclinical models poorly predict human drug efficacy, particularly in neurological disorders.
We develop a dual-rule contrastive learning framework that aligns corresponding mouse and human states while preserving separation between distinct phenotypes.
Extractive summary: sentences quoted from the sources.